BeStock  
Stocks › Biotechnology › MLTX

MoonLake Immunotherapeutics MLTX

US equityMarket cap rank #3205Biotechnology
$11.07 +$0.04 (+0.36%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $11.07 0.00%
Open$10.79
Prev close$11.03
Day range$10.73 – $11.31
Volume1.72M
Market cap$942.13M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-3.4x
CheapRich

Near the top of its 5-year range · 87th percentile, 5-year average -26.0x

Price / book2.8x
CheapRich

Near the bottom of its 5-year range · 19th percentile, 5-year average 6.9x

#3637 of 5329 stocks by PB (1 = cheapest)

P/E over five years

-78x-50x-22x6xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$15.51
Price vs. fair value-28.6%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.79 – 6.86 19% (cheaper than usual) #3637 of 5329 (1 = cheapest)
PE -3.42 -3.37 -26.04 87% (pricier than usual) –
PS – 1,180.20 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on MLTX.

Sign in to join the discussion.

Scroll to Top